Vomacur® 70 mg suppositories, 5 pcs

Vomacur® 70 mg suppositories

Vomacur® 70 mg suppositories is a medicine used to prevent and treat motion sickness, dizziness, nausea and vomiting.It belongs to the group of H1 antihistamines.No prescription is required for this product.

The active ingredient dimenhydrinate acts against nausea and vomiting and prevents motion sickness.It binds to the H1 receptors and thereby counteracts the excess of histamine released.

Ingredients

Vomacur® 70 mg suppositories contain the active ingredient dimenhydrinate.One suppository contains 70 mg dimenhydrinate.Hard fat is also included as an additional ingredient.

Area of application

Vomacur® 70 mg suppositories are used to prevent and treat motion sickness, dizziness, nausea and vomiting.However, it is not suitable for the sole treatment of nausea and vomiting associated with drug treatment for cancer (cytostatic therapy).

Contraindications

Vomacur® 70 mg suppositories must not be used in cases of hypersensitivity to dimenhydrinate, other antihistamines or any of the other ingredients, in acute asthma attacks, glaucoma (angle-closure glaucoma), adrenal gland tumor (pheochromocytoma), disorder of the production of blood pigment (porphyria), enlargement of the prostate gland (prostatic hyperplasia) with residual urine formation and in case ofSeizures (epilepsy, eclampsia).

Dosage

The dosage of dimenhydrinate should be based on the patient's body weight.For small and light children, a single dose of the lowest dosage in the respective weight or age group can be enough to relieve the symptoms.

The usual dose is:

Children weighing 15 to 25 kg: 1 suppository once daily.

Children weighing 25 to 40 kg: 1 suppository twice daily.

Children weighing more than 40 kg and adolescents aged 14 and over: 1 suppository 2 to 3 times daily.

The maximum daily doses are:

Children 6 to 14 years: maximum 150 mg dimenhydrinate per day.

Adolescents aged 14 and over: maximum 400 mg dimenhydrinate per day.

The medicine is only intended for short-term use.If symptoms persist, a doctor should be consulted.After 2 weeks of treatment at the latest, your doctor should check whether treatment is still necessary.

Intake

Vomacur® 70 mg suppositories are not intended to be taken orally.To prevent motion sickness, the first dose should be given approx. 1/2 - 1 hour before the start of the journey.To treat nausea and vomiting, doses are given at regular intervals throughout the day.The suppositories should be inserted deep into the rectum.

Patient information

Particular caution in use is required in cases of impaired liver function, cardiac arrhythmias, potassium or magnesium deficiency, slow heartbeat, certain heart diseases, simultaneous use of drugs that prolong the QT-interval in the EKG or lead to hypokalemia, chronic breathing difficulties and asthma, narrowing at the outlet of the stomach and children under 6 years of age.In these cases, the medicine may only be used after consulting your doctor.

Drowsiness, memory problems and reduced ability to concentrate can have an adverse effect on the ability to drive or work with machines.This is particularly true after insufficient sleep, when starting treatment and changing medications, and in combination with alcohol.

Pregnancy

Before use, ask your doctor or pharmacy for advice.Tell your doctor if you are pregnant or planning to become pregnant.Dimenhydrinate can cause premature labor.The safety of use during pregnancy has not been proven.

Tell your doctor if you are breast-feeding.Dimenhydrinate passes into breast milk.The safety of use during breastfeeding has not been proven.Since undesirable effects, such as increased restlessness, on the breast-fed child cannot be ruled out, you should either not use the medicine while breast-feeding or stop breast-feeding while it is being used.

The medicine should not be used in children under 6 years of age.

Notes

Keep out of the reach of children.Vomacur® 70 mg suppositories may only be used in children with a body weight of 15 kg or more (from 6 years).After using dimenhydrinate, skin sensitivity to light may occur, so avoid direct sunlight.

Please do not use this medicine after the expiry date stated on the pack or outer packaging.The expiry date refers to the last day of the specified month.